(Q35122814)

6 August 2017

title

A single-centre experience of post-renal transplant lymphoproliferative disorder (English)

1 reference

6 August 2017

6

Carmel M Hawley

1 reference

6 August 2017

Karen A Herzig

1

1 reference

6 August 2017

Helen G Juffs

2

1 reference

6 August 2017

Debra Norris

3

1 reference

6 August 2017

Allison M Brown

4

1 reference

6 August 2017

Devinder Gill

5

1 reference

6 August 2017

Ralph Cobcroft

7

1 reference

6 August 2017

James B Petrie

8

1 reference

6 August 2017

Paula Marlton

9

1 reference

6 August 2017

Damien Thomson

10

1 reference

6 August 2017

Scott B Campbell

11

1 reference

6 August 2017

David L Nicol

12

1 reference

6 August 2017

David W Johnson

13

1 reference

6 August 2017

publication date

7 May 2003

1 reference

6 August 2017

published in

Transplant International

1 reference

6 August 2017

volume

16

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

529-536

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Clinical characteristics of post-transplant lymphoproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

Diagnosis and treatment of transplant-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00343.X

10.1111/J.1432-2277.2003.TB00343.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference